| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
5,768 |
1,154 |
$165K |
| 87631 |
|
1,555 |
1,478 |
$155K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,228 |
1,994 |
$80K |
| 70450 |
Computed tomography, head or brain; without contrast material |
866 |
786 |
$76K |
| 80053 |
Comprehensive metabolic panel |
5,523 |
4,648 |
$72K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
514 |
451 |
$58K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,637 |
6,275 |
$51K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
822 |
720 |
$49K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,115 |
994 |
$47K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,645 |
2,151 |
$45K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
985 |
927 |
$45K |
| 97161 |
|
636 |
555 |
$37K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,628 |
1,540 |
$23K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,503 |
2,119 |
$22K |
| 80050 |
General health panel |
572 |
455 |
$21K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
618 |
576 |
$20K |
| 71046 |
Radiologic examination, chest; 2 views |
1,216 |
1,128 |
$20K |
| 71045 |
Radiologic examination, chest; single view |
2,184 |
1,875 |
$17K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,868 |
1,540 |
$17K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
393 |
335 |
$15K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
58 |
56 |
$14K |
| 80061 |
Lipid panel |
1,156 |
1,027 |
$11K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
485 |
458 |
$11K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
329 |
302 |
$10K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
43 |
40 |
$10K |
| 84484 |
|
1,509 |
1,154 |
$9K |
| 36415 |
Collection of venous blood by venipuncture |
2,331 |
1,923 |
$9K |
| 81025 |
|
1,031 |
926 |
$8K |
| 0001A |
|
211 |
205 |
$8K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
409 |
363 |
$8K |
| 0002A |
|
181 |
180 |
$8K |
| 82553 |
|
1,090 |
895 |
$8K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
259 |
237 |
$7K |
| 73560 |
|
210 |
163 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
858 |
777 |
$7K |
| 83735 |
|
1,434 |
1,204 |
$7K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
93 |
86 |
$7K |
| 81001 |
|
2,332 |
2,088 |
$6K |
| 83690 |
|
934 |
838 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
161 |
141 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,065 |
942 |
$6K |
| 82550 |
|
1,070 |
887 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
592 |
525 |
$6K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
179 |
166 |
$4K |
| 83880 |
|
256 |
208 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
81 |
76 |
$4K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
81 |
76 |
$4K |
| 82150 |
|
542 |
491 |
$3K |
| 83605 |
|
348 |
307 |
$3K |
| 85730 |
|
780 |
668 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
221 |
206 |
$2K |
| 20610 |
|
104 |
86 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
158 |
147 |
$2K |
| 85610 |
|
970 |
812 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
91 |
81 |
$2K |
| 86756 |
|
134 |
118 |
$2K |
| 87186 |
|
573 |
494 |
$2K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
24 |
24 |
$2K |
| 81003 |
|
824 |
749 |
$2K |
| 83655 |
|
111 |
109 |
$2K |
| 73630 |
|
77 |
66 |
$2K |
| 82962 |
|
305 |
212 |
$2K |
| 74018 |
|
105 |
95 |
$2K |
| 80320 |
|
108 |
93 |
$2K |
| 87088 |
|
297 |
266 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
511 |
455 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
349 |
317 |
$1K |
| 73130 |
|
43 |
38 |
$886.69 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
13 |
13 |
$860.00 |
| 73610 |
|
45 |
37 |
$852.51 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
12 |
12 |
$785.27 |
| 87040 |
|
60 |
51 |
$782.34 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
137 |
116 |
$710.65 |
| 73562 |
|
28 |
26 |
$694.37 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
97 |
84 |
$515.16 |
| 0012A |
|
67 |
67 |
$421.53 |
| 86901 |
|
14 |
12 |
$395.09 |
| 0011A |
|
68 |
68 |
$392.80 |
| 84439 |
|
30 |
28 |
$326.14 |
| 73030 |
|
14 |
13 |
$320.95 |
| 80143 |
|
14 |
12 |
$319.10 |
| 80179 |
|
14 |
12 |
$319.10 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
88 |
68 |
$276.00 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
974 |
917 |
$252.25 |
| 72100 |
|
12 |
12 |
$241.10 |
| 82803 |
|
16 |
12 |
$229.05 |
| 84145 |
|
18 |
14 |
$226.65 |
| 82565 |
|
12 |
12 |
$218.39 |
| 85018 |
|
48 |
37 |
$147.60 |
| 82728 |
|
12 |
12 |
$136.22 |
| 82607 |
|
17 |
14 |
$129.12 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
41 |
40 |
$48.31 |
| 85651 |
|
13 |
12 |
$47.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
34 |
30 |
$29.76 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
64 |
58 |
$8.73 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
31 |
27 |
$8.01 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
64 |
44 |
$8.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
28 |
28 |
$3.66 |
| G0008 |
Administration of influenza virus vaccine |
15 |
12 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
42 |
39 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
13 |
12 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
18 |
18 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
19 |
16 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
20 |
14 |
$0.00 |